Quick Answer
Lipocine Inc. reported Stockholders Equity of $14.48 million for the year ending 2025.
- Lipocine Inc. showed a decrease of -31.1% in Stockholders Equity from 2024 to 2025.
- This data is from Lipocine Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: $24.8 thousand | Q3 2012: -$6.4 thousand | Q1 2013: -$14.5 thousand | Q2 2013: -$17.6 thousand | Q3 2013: $35.54 million | Q1 2014: $40.60 million | Q2 2014: $33.82 million | Q3 2014: $29.96 million | Q1 2015: $23.72 million | Q2 2015: $52.13 million | Q3 2015: $46.25 million | Q1 2016: $35.78 million | Q2 2016: $30.76 million | Q3 2016: $27.98 million | Q1 2017: $24.88 million | Q2 2017: $25.15 million | Q3 2017: $23.77 million | Q1 2018: $16.67 million | Q2 2018: $13.88 million | Q3 2018: $11.76 million | Q1 2019: $12.55 million | Q2 2019: $9.85 million | Q3 2019: $7.51 million | Q1 2020: $6.55 million | Q2 2020: $13.08 million | Q3 2020: $14.51 million | Q1 2021: $42.39 million | Q2 2021: $35.75 million | Q3 2021: $32.81 million | Q1 2022: $42.41 million | Q2 2022: $39.89 million | Q3 2022: $37.65 million | Q1 2023: $31.96 million | Q2 2023: $28.55 million | Q3 2023: $22.48 million | Q1 2024: $23.96 million | Q2 2024: $21.21 million | Q3 2024: $19.12 million | Q1 2025: $19.20 million | Q2 2025: $17.13 million | Q3 2025: $14.14 million.
- Over the full 15 years of available data (2011 to 2025), Lipocine Inc.'s Stockholders Equity has grown by 1,012.1%.
- Historical annual values: Fiscal year 2025: $14.48 million | Fiscal year 2024: $21.00 million | Fiscal year 2023: $20.37 million | Fiscal year 2022: $35.63 million | Fiscal year 2021: $45.57 million | Fiscal year 2020: $15.34 million | Fiscal year 2019: $6.29 million | Fiscal year 2018: $9.43 million | Fiscal year 2017: $18.98 million | Fiscal year 2016: $26.02 million | Fiscal year 2015: $41.99 million | Fiscal year 2014: $26.36 million | Fiscal year 2013: $44.82 million | Fiscal year 2012: $5.32 million | Fiscal year 2011: $1.30 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: